The E2F transcription factors are key targets for the retinoblastoma protein, pRB. By inactivation of E2Fs, pRB prevents progression to the S phase. To test proliferative functions of E2F, we generated transgenic mice expressing human E2F-1 and/or human DP-1. When the hydroxymethyl glutaryl coenzyme A reductase promoter was used to express DP-1, overexpression occurred in a variety of tissues and did not confer phenotypic changes. In contrast, expression of E2F-1 from the same promoter was obtained only in testicles, in which E2F-1 overexpression caused atrophy and sterility through a process involving increased apoptosis in the germinal epithelium. This eect was potentiated by simultaneous overexpression of DP-1. Testicular atrophy as a result of overexpression of E2F-1 and DP-1 is independent of functional p53, since p53-nullizygous transgenic mice overexpressing E2F-1 and DP-1 also suered testicular atrophy.
Introduction
The E2F transcription factors are essential for the orderly progression through the mammalian cell cycle. E2F is a main target of the prototypic tumor suppressor protein pRB (for a review, see Weinberg, 1995) . The RB-1 gene was cloned by virtue of chromosomal location and homozygous inactivation in retinoblastoma (Friend et al., 1986; Lee et al., 1987) . The importance of RB-1 in suppressing tumor development is underscored by the fact that it is also frequently inactivated in carcinomas of the lung, prostate, and cervix, and in osteosarcomas (Weinberg, 1995) .
The tumor-suppressing function of pRB has been demonstrated in experiments with tumor-derived cell lines that carry two non-functional RB-1 alleles. When the wild type pRB-1 allele is re-introduced into such cell lines, G1-arrest is restored and the tumorigenic potential is lost (Huang et al., 1988; Bookstein et al., 1990; Takahashi et al., 1991) . Injection of recombinant pRB revealed that pRB exerts its growth-suppressive function in mid-to-late G1, after which the cells become committed to S phase and are resistant to pRB overexpression (Goodrich et al., 1991) . Loss of functional pRB is associated with either transformation or apoptosis. RB nullizygous mice die in utero, presumably due to widespread neural apoptosis and defects in the haematopoietic system (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . The papilloma virus oncoprotein E7 binds and inactivates pRB (MuÈ nger et al., 1989) . Expression of E7 from a tissue-speci®c promoter in transgenic mice causes apoptosis. In the absence of the p53 protein, however, apoptosis is largely circumvented and oncogenic transformation occurs instead (Howes et al., 1994; Griep, 1994, 1995) . In an investigation of the developing lens in mouse embryos, Morgenbesser and collaborators showed that, while there is massive apoptosis in RB null lenses, there is an almost no apoptosis when p53 is also absent (Morgenbesser et al., 1994) . Indeed, germline mutations of the mouse RB and p53 tumor suppressor genes cooperate in tumorigenesis in mice. Furthermore, human tumor cells with inactivated RB-1 alleles frequently have inactive p53 genes . In fact, loss of functional p53 occurs in more than 50% of human tumors (Levine, 1993) , and mice homozygous for targeted disruptions or deletions of p53 develop tumors, mainly of lymphoid origin, within six months of age (Donehower et al., 1992; Jacks et al., 1994; Purdie et al., 1994) .
The pRB protein binds directly to E2F transcription factors in vivo (Bagchi et al., 1991; Bandara and La Thangue, 1991; Chellappan et al., 1991; Chittenden et al., 1991) . E2F was originally de®ned as a cellular factor involved in E1A-mediated induction of the adenoviral E2-promoter (Kovesdi et al., 1986) . Subsequently, E2F has been shown to be involved in the transcriptional regulation of several genes whose products participate in cell cycle progression and DNA synthesis, and whose expression is upregulated at the G1/S-boundary of the cell cycle (Blake and Azizkhan, 1989; Thalmeier et al., 1989; Dalton, 1992; Singh et al., 1994) . The ability of pRB to bind E2F coincides with its ability to prevent traversal of G1 and correlates with an inhibition of E2F-mediated transcriptional activation (Hiebert et al., 1992; Helin et al., 1993a) .
Proteins of the E2F and DP families heterodimerize to generate E2F activity. The prototype, E2F-1, was cloned as a cDNA encoding a pRB-binding polypeptide. The carboxy terminal of E2F-1 contains a potent transcription activation domain, part of which is also responsible for binding to pRB (Helin et al., 1992; Kaelin et al., 1992; Shan et al., 1992) . Four cDNAs of genes with extensive homology to E2F-1 have been isolated; their proteins have been named E2F-2, E2F-3, E2F-4 and E2F-5 (Ivey-Hoyle et al., 1993; Lees et al., 1993; Beijersbergen et al., 1994; Ginsberg et al., 1994; Hijmans et al., 1995; Sardet et al., 1995) . E2F-1, E2F-2, and E2F-3 also interact with pRB, whereas E2F-4 and E2F-5 were isolated as targets of the pRB-related proteins p107 and p130. Recent data have shown that E2F-4 and E2F-5 can also bind pRB (Ikeda et al., 1996; Moberg et al., 1996; K Helin, unpublished results) , demonstrating that pRB can regulate all known proteins that generate E2F activity. The DP family consists of two proteins, DP-1 and DP-2, both of which can bind to all members of the E2F family (Girling et al., 1993; Ormondroyd et al., 1995; . The E2F/DP heterodimers have high anity for E2F-DNA-binding sites and can transactivate an E2F-dependent promoter Helin et al., 1993b; Krek et al., 1993; Wu et al., 1995) .
Since E2F appears crucial for correct cell-cycleregulated transcription of genes involved in progression to and traversal of S phase, several groups have tested the potential S-phase-inducing and oncogenic functions of the E2Fs. Overexpression of E2F may mimic loss of pRB function, since pRB may become limiting for the repression of E2F-mediated transcriptional activation. Indeed, microinjection of recombinant E2F-1 forces cells into S phase as does overexpression obtained by either transient transfection, induction in stably transfected cells, or viral infection (Johnson et al., 1993; Qin et al., 1994; Shan and Lee, 1994; Kowalik et al., 1995; Lukas et al., 1996) . E2F-1 has also been shown to transform immortalized ®broblasts (Singh et al., 1994; Xu et al., 1995) , to cooperate with activated Ras in the transformation of rat ®broblasts (Johnson et al., 1994) , and to cooperate with human papilloma virus E6 and E7 mutant proteins in immortalizing primary human keratinocytes (Mellilo et al., 1994) . Thus, papilloma virus E7 mutants that cannot inactivate the pRB family of proteins do not immortalize primary cells; these E7 mutants but not other E7 mutants can be helped by E2F-1 transfection (Mellilo et al., 1994) . In some cell lines, overexpression of E2F-1 has been shown to cause apoptosis that appears to be dependent on functional p53 (Qin et al., 1994; Shan and Lee, 1994; Wu and Levine, 1994; Hiebert et al., 1995; Kowalik et al., 1995) .
In short, previous knowledge predicts that, E2F activity is rate-limiting for S phase entry. Furthermore, ectopic E2F activity should result in either apoptosis or tumor formation depending on the presence or absence of functional p53. To test these predictions we have generated transgenic mice overexpressing E2F-1, DP-1, or the two proteins together after a promoter that often causes wide-spread expression. DP-1 overexpression occurred in a variety of tissues without any apparent phenotypic consequence. In contrast, we could not generate mice with widespread expression of the E2F-1 transgene. We did get two E2F-1 transgenic lines, in which E2F-1 was overexpressed in testicles, however. One of these lines had reduced testis size, atrophy of the seminferous tubules and male sterility. Testicular atrophy also occurred in the other line, albeit with reduced penetrance. In this line, the penetrance and severity of the atrophy was enhanced by simultaneous DP-1 overexpression. Microscopic examinations including the use of the TUNEL assay revealed apoptosis in those testicles. Finally, the testicular atrophy and increase in apoptosis caused by E2F-1, alone or in combination with DP-1, are independent of p53, and the E2F-1 and DP-1 transgenes are unlikely to contribute to tumorigenesis in the testes of p53 knockout mice.
Results

DNA constructs and transgenic lines
To test the growth-stimulatory potential of the transcription factors E2F-1 and DP-1 in vivo we generated transgenic mice that overexpress either or both of these. Trying to achieve widespread expression, we used a`housekeeping' promoter, namely that of the mouse hydroxy-methyl-glutaryl-Coenzyme A reductase (HMG) gene. This promoter has previously been used to direct the expression of transgenes to a plethora of tissues (Gautier et al., 1989) . We inserted cDNA of human origin encoding either E2F-1 or DP-1 into the expression vector pHMG (Gautier et al., 1989) to generate pHMG-E2F-1 and pHMG-DP-1, respectively. Schematic drawings of the two constructs as excised from the vector backbone before microinjection are shown in Figure 1 .
Five independent HMG-DP-1 lines (termed HD1 through to HD5) were established. Expression of the transgenes in lines HD1, HD2 and HD5 were only detectable in testis as measured by Northern blot hybridization (results not shown), and these lines were not analysed further. HD3 expressed the transgene in brain, heart, spleen, thymus and testis ( Figure 2a) . In line HD4, we detected transgenic expression in all the tissues tested (Figure 2b ). In both lines expression was strongest in testis. Western blot analysis con®rmed the overexpression of DP-1 at the protein level in testis, liver, and muscle from line HD4. Figure 3 shows that the level of overexpression in these tissues ranges from two-to ®vefold. We have not detected any phenotype concerning life span, behavior, or histopathology in mice carrying the DP-1 transgenes.
With the HMG-E2F-1 construct we generated ten independent potential founder animals. However, eight of those were either sterile or unable to transmit the transgene to their progeny. Thus, only two lines, termed HE3 and HE5, were established. The HE5 transgene is located on the X chromosome, as transgenic males transmitted the transgene to all female progeny, but never to male progeny: 25 litters obtained from crosses involving HE5 transgenic males and wild type females yielded 89 male pups of which none carried the HE5 transgene, whereas all 65 female ospring were HE5 transgenic. Litters from HE5 female mice showed normal mendelian distribution of transgene inheritance.
Testes-speci®c eects of excess E2F activity
We examined transgenic expression in ten dierent tissues of the two HMG-E2F-1 lines by Northern blot hybridization and found expression only in testis (Figure 4 and results not shown). As is evident from Figure 4 , transgenic expression diered between the two lines in that two transcripts of slightly dierent lengths were detected in HE3 testicles, whereas only the longer of the two was detected in HE5 testicles. It has previously been reported that dierent transcript lengths can be detected from pHMG-derived transgenes, presumably due to alternative splicing patterns of the large HMG intron present in these constructs (Gautier et al., 1989) . Thus, we presume that the two transcripts in line HE3 testicles arise as a consequence E2F induces p53-independent apoptosis C Holmberg et al of alternative splicing of the untranslated 5'-terminal part of the transcript. The testis expression in line HE3 correlated with a striking phenotype of male sterility and small atrophic testicles (see later). Due to this male sterility and due to the fact that females had reduced fertility, we could not maintain this line. A total number of ®ve male HE3 mice was obtained. All these males had testicular weights below 50% of that of their wild type litter mates. Small atrophic testicles were also observed in examined males from line HE5, but with incomplete penetrance. The histograms A and B in Figure 5 show Figure 1 Structure of the HMG-E2F-1 and HMG-DP-1 transgenes. E2F-1 and DP-1 cDNA is preceded by the promoter (*1.3 kb), ®rst untranslated (UTR) exon (*0.7 kb) and ®rst intron (*3.4 kb) from HMG, and followed by a polyadenylation signal derived from SV40 (*0.2 kb) as indicated. Length of E2F-1 cDNA is 1.35 kb and length of the DP-1 cDNA is 1.6 kb. The HMG-E2F-1 and HMG-DP-1 constructs are shown as the NotI restriction fragments used for micro injection with total size indicated Figure 2 Northern blot analysis of transgenic DP-1 expression in lines HD3 (a) and HD4 (b). The transgenic transcripts (DP-1) run right above 18S ribosomal RNA (18S). RNA extracted from wild type female liver and from wild type testicles were run in the left and right¯anking lanes, respectively and serve as negative controls (wt liver and wt testis). The blots were also hybridized to a bactin probe for control of integrity and loading (b-actin). The RNA originates from 6-week-old mice in all cases the distributions between weight classes of testicles sampled from 42 ± 44 day old mice, either wild type (in A) or HE5 transgenic mice (in B). There is a shift towards lower weight classes in the HE5 transgenic set, which had a mean of 60 mg (standard deviation, s=20) compared to a mean of 79 mg (s=13) for wild type testicles. Thirty-six percent of the HE5 testicles fell in low weight classes that did not occur in the wild type set (and represent testicular weights that are more than two standard deviations below the wild type mean). On the basis of this distribution, we have de®ned the penetrance of the phenotype in line HE5 as 36% versus 100% in line HE3.
Cooperative eects of E2F-1 and DP-1 transgenes
The DP-1 transgenes had no eect on their own: from 17 mice, the mean testicle weight was 81 mg, which is not signi®cantly dierent from the mean of wild type testicles, 79 mg. However, as DP-1 assists E2F-1 in transcriptional activation of a target promoter (Helin et al., 1993b; Bandara et al., 1993) , we tested whether ectopic expression of DP-1 could increase the penetrance of testicular atrophy in line HE5. We thus crossed HE5 females with HD3 or HD4 males. Indeed, HE5/HD3 or HE5/HD4 double transgenic males had further reduced testicle weights (mean weight 40 mg, s=17) as compared to the eect of the HE5 transgene alone ( Figure 5 , compare histograms B and C). Ectopic expression of DP-1 not only increased the penetrance (76% present in low weight groups not present in the wild type set), but also resulted in a further decreased testis size in aected animals. The median weights were 80.5 mg for wild type, 81.0 mg for HD3 or 4; 59.6 mg for HE5; and Figure 4 Northern blot analysis of transgenic E2F-1 expression in testicles of HE3 and HE5 males. RNA from wild type testicles was included in the analysis (WT). The transgenic transcripts run right below 18S ribosomal RNA (18S). The blot was also hybridized to a b-actin probe for control of integrity and loading. Note the absence of the shorter b-actin transcript in HE3. RNA was extracted from 6-week-old animals Figure 5 Histograms showing the distribution of testicle weights from 42 ± 44 day old mice, either wild type, HE5-transgenic or double-transgenic (HE5/HD). Among the double-transgenic HE5/ HD no distinction was made between the HD transgenes 3 and 4, since their eects on testicles were indistinguishable. Number of testicles in each group is indicated (n). Percentage of n in each weight interval is plotted for each group E2F induces p53-independent apoptosis C Holmberg et al 36.0 mg for HE5/HD. Mann ± Whitney U-tests proved that the dierences among the three groups compared in Table 1 are statistically signi®cant.
Atrophy and apoptosis related to transgene expression
Histological examination of transgenic testicles from six-week-old animals demonstrated dierent degrees of typical secondary testicular atrophy with 5 ± 100% of tubuli showing depletion of germ cells ( Figure 6 and results not shown). There was a general correlation between a reduced weight and degree of seminiferous tubular atrophy. The most strongly atrophied tubuli were devoid of germ cells and retained only Sertoli cells along the basement membrane ( Figure 6f ). As E2F-1 overexpression in cell cultures can cause apoptosis (Qin et al., 1994; Shan and Lee, 1994; Wu and Levine, 1994; Kowalik et al., 1995) , we looked for the presence of apoptotic cells in these sections. Indeed, groups of such cells, with the characteristic pycnotic appearance of the nucleus and shrunken, homogeneously eosiniophilic cytoplasm, were found in some sections of the atrophic transgenic testicles (Figure 6e and f). Interstitial Leidig cell atrophy was not observed. Rather, strongly atrophic testicles often showed extensive Leidig cell hyperplasia. In wild type six-week-old mice apoptotic testicular cells were extremely rare (Figure 6a and b). That was also true for HMG-DP-1 transgenics of the same age. We veri®ed apoptosis by the TUNEL assay (Gavrieli et al., 1992) in the six-week-old HE3 testicles (compare the wild type in Figure 7a with the HE3 testicles in Figure 7b , c and d). As ongoing apoptosis detected in testicles from six-week-old transgenic animals was limited, we presumed that the testicular atrophy was due in part to apoptosis at earlier stages. Indeed, more cells were undergoing apoptosis in TUNEL-stained testis sections made from a two-week-old HE5 transgenic animal (Figure 7f ). However, we also detected considerable apoptosis in a testicle from a wild type animal at this point of development. There was a dierence in distribution, though. While apoptosis in the wild type seemed randomly spread, massive apoptosis was evident within single tubules in the HE5 transgenic testicle. Such apoptosis probably causes the tubule to become atrophic (compare Figure  7e and f) .
The small testicle phenotype may arise from developmental eects or from deterioration in testicles at later stages. We have measured strong mass reduction of the testicles in a one-week-old HE5/HD3 transgenic male as compared to wild type and HD3 litter mates (approximately 3 mg versus approximately 6 mg), thus indicating that the eect sets in at an early stage. Also early developmental eects may be due to apoptosis, although other eects may contribute: For instance, excess E2F activity may disturb differentiation or interfere with the meiotic cycle.
Approximately two-thirds of HE5 transgenic males were normal, and even in the HE5/HD3 and HE5/HD4 transgenic group there were some with normally sized testicles. A possible explanation for the incomplete penetrance could be that normally sized testicles from these transgenic groups randomly express the transgenes at a lower level than the small atrophic testicles from the same groups. Trying to detect such a dierence, we compared the amounts of transgenic E2F-1 protein between normal and reduced size testicles from six-week-old HE5 males by immunological assays. In direct Western blots we could not detect any human E2F-1. The extremely low levels of E2F-1 in the testicles with easily detected mRNA may be explained by the recent ®nding that E2F-1 that is not bound to pRB gets rapidly degraded by the ubiquitinproteasome pathway (Hateboer et al., 1996; Hofmann et al., 1996; Campanero and Flemington, 1997) . Western blot analysis of immunoprecipitated E2F-1 from testicular extracts did not reveal more E2F-1 in atrophic testicles than in normal testicles from sixweek-old transgenic mice (Figure 8 ). At 6 weeks, where only few apoptotic cells were detected, more strongly expressing cells may be too few to contribute a signi®cant fraction to the total amount of the total E2F-1. While subtle dierences in genetic background or in environmental factors that aect the growth and development of testicles could in principle decide which males become more aected, a more likely reason is discussed in the following.
The transgene-related apoptosis was concentrated in local areas both at 2 weeks and at 6 weeks, probably due to uneven expression of the transgene within the tissue. Such a pattern of patchwise or`variegated' expression, has also been observed for several other transgenes (Bradl et al., 1991; Furth et al., 1994; Robertson et al., 1995; Dobie et al., 1996 Dobie et al., , 1997 .`Mosaicism' is sometimes used to designate the same phenomenon, but variegation may be a more distinctive term to indicate that the transgenic genotype is homogenous, while its phenotypic expression is mosaic. Interestingly, variegation is characteristically connected to great variability in total transgene expression between individuals of the same transgenic lineage (Furth et al., 1994; Robertson et al., 1995; Dobie et al., 1996 Dobie et al., , 1997 , an eect that appears unrelated to the dierences in background (Dobie et al., 1996) . Thus at any one time a small number of cells may express a signi®cant excess of E2F. This may be sucient to cause dramatic atrophy and reduced size of testicles in some aected males while sparing others.
We have tried to evaluate E2F-1 expression in single cells by anti-E2F-1 immunohistochemistry on HE3 testis sections. Although hampered by strong unspeci®c background staining, those experiments (not shown) suggested that cells undergoing apoptosis expressed higher E2F-1 levels, i.e. detectable levels, than the normal cells (levels below detection limit). This result supports our hypothesis that testicular atrophy is the consequence of unscheduled apoptosis in cells with excess E2F-activity. 
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The role of p53 in apoptosis induced by the transgenes The p53 protein is involved in executing cell cycle arrest or apoptosis in response to DNA damage (Kastan et al., 1991; Clarke et al., 1993; Lowe et al., 1993) and can also trigger apoptosis in cells that enter unscheduled S phase due to loss of pRB function (Howes et al., 1994; Morgenbesser et al., 1994; Pan and Griep, 1994) . E2F-1 overexpression in serum-deprived cell cultures leads to DNA synthesis and subsequent apoptosis (Qin et al., 1994; Shan and Lee, 1994; Wu and Levine, 1994; Kowalik et al., 1995) , and this E2F-1-induced apoptosis is strongly reduced in the absence of functional p53 (Qin et al., 1994; Wu and Levine, 1994; Kowalik et al., 1995) . Therefore, we have tested whether lack of p53 could rescue the apoptotic/ atrophic phenotype in the testicles of our transgenic mice and lead to tumorigenesis instead.
To analyse the eects of the transgenes in a p53 nullizygous background we obtained mice heterozy- E2F induces p53-independent apoptosis C Holmberg et al gous for a deletion from exon 2 to exon 6 in the p53 gene (Clarke et al., 1993) from Alan Clarke, Edinburgh. Those animals, which were in a strain 129 background, we used to cross to our transgenic mice. Thus, the mice reported below are mixtures of the CBA, C57/Bl/6 and 129 strains. This is noteworthy, since teratoma of the testis is the most common tumor in strain 129 (Stevens, 1973) .
The HE5, HD3, and HD4 transgenic lines were cross-bred to a p53 heterozygous background. Further crosses eventually gave rise to mice transgenic for HE5, HE5/HD3, or HE5/HD4 in the p53 nullizygous background. The mean testicle weight was somewhat higher in this strain background (Table 2) . Importantly, however, the eect of the transgenes on testicle size was very similar to that in the p53 7/7 mice. The Apoptotic cells were also detected in the testicle from a two-week-old wild type animal in (e), but with reduced frequency as compared to an HE5 transgenic litter mate in (f). No staining was observed when either biotinylated dUTP or terminal transferase was omitted in the assay (results not shown). Initial magni®cations were 100 times in a, b, e and f. They were 400 times in c and d mean weights in p53 7/7 mice were 103, 70 and 55 for nontransgenic, HE5, and HE5/HD, respectively, and the median weights in p53 7/7 mice were 104, 70 and 50 for nontransgenic, HE5 and HE5/HD, respectively. According to the Mann ± Whitney U-tests the differences between the nontransgenic p53 7/7 and the p53 7/7 HE5 mice were statistically signi®cant (P=0.021) and so were the dierences between the nontransgenic p53 7/7 and the p53 7/7 HE5/HD mice (P=0.018). Thus, lack of p53 did not prevent the reduction in testicular weight. Other aspects of the phenotype were also untouched: as evident from the photomicrographs in Figure 9 , apoptosis and atrophy of the seminferous tubules were still seen in HE5 p53 7/7 testicles. Thus, whereas published results have shown that the E2F-1-induced apoptosis in ®broblasts is largely circumvented in the absence of functional p53 (Qin et al., 1994; Wu and Levine, 1994; Kowalik et al., 1995) , the eects on testicles caused by E2F-1 and E2F-1/DP-1 transgenes were p53-independent.
One animal with the HE5/HD3 p53 7/7 genotype developed a testicular teratoma at 12 weeks of age. Similarly, one 6 week-old HD3 p53 7/7 animal had one such tumor. The mean age before sacri®ce or death due to tumor development was 126 days for nontransgenic p53 7/7 animals (11 males and two females), 126 days for HD3 p53 7/7 and HD4 p53 7/7 animals (21 males), 129 days for HE5 p53 7/7 animals (eight males) and 124 days for HE5/HD p53 7/7 animals (nine males). The vast majority of the tumors were either lymphomas or osteosarcomas, in agreement with previously published results for p53 7/7 mice (Donehower et al., 1992; Jacks et al., 1994; Purdie et al., 1994) . From these results we conclude that the HMG-DP-1 and HMG-E2F-1 transgenes do not accelerate tumorigenesis in p53 7/7 mice, although we cannot rule out completely the possibility of a slightly increased incidence of testicular tumors. To con®rm that, a larger cohort would have to be followed. However, we ®nd it likely that the two testis tumors observed were caused by lack of p53 in the partial strain 129 background with its known propensity for testicular teratomas rather than by an oncogenic eect of the transgenes. In their original background, a mixture of the inbred strains CBA and C57Bl/6, the HE5/HD mice did not get testis tumors.
Discussion
Testicular atrophy in animals with excess E2F expression in testicles
Previous studies have attributed both apoptotic and oncogenic activities to E2F-1 (Johnson et al., 1994; Qin et al., 1994; Shan and Lee, 1994; Singh et al., 1994; Wu and Levine, 1994; Hiebert et al., 1995; Kowalik et al., 1995; Xu et al., 1995) . Recently, also tumor-suppressing functions have been assigned to E2F-1, as mice homozygous for a targeted disruption of the E2F-1 gene are prone to tumor development (Field et al., 1996; Yamasaki et al., 1996) . The latter function may re¯ect the fact that pRB requires E2F-1 as a bridge, when it acts as an active repressor of a class of promoters with E2F sites (Bremner et al., 1995; Sellers et al., 1995; Weintraub et al., 1995) .
With DP-1 under transcriptional control of the HMG promoter we obtained DP-1 overexpression in a variety of tissues with no apparent consequences as long as E2F-1 was not also overproduced. This ®nding is consistent with the fact that DP-1 overexpression in tissue culture leads to only modest activation of the E2F-dependent promoter, suggesting that DP-1 is not limiting in the cell Helin et al., 1993b; Krek et al., 1993) .
In contrast to the widespread expression with HMG-DP-1, the two HMG-E2F-1 transgenic lines express only in testicles among many tested tissues. In these lines, HE3 and HE5, expression correlated with Figure 8 Transgenic E2F-1 expression in normal and reduced size HE5 transgenic testicles is similar. E2F-1 was immunoprecipitated from 1 mg of testis extract with a combination of two monoclonal antibodies (KH20 and KH95) recognizing independent E2F-1 epitopes. The immunoprecipitates were used for Western blotting, where E2F-1 was detected with a polyclonal antibody raised against a synthetic peptide covering the pRBbinding domain in human E2F-1. As a positive control, extract from LB6 cells transiently transfected with pCMV-E2F1 was included. Extract from a wild type testicle serves as a negative control. The origin and weight of the testicles used in the experiment is indicated above each lane. Testicles were taken from 6-week-old mice. The ®nal detection antibody shows some crossreactivity to the heavy chain of the mouse monoclonal antibodies used for precipitation (IgG hc). Positions of molecular weight standards are indicated on the left. An independent experiment gave the same result a Testicles from 42 ± 44 day old males were weighed. Parentheses are used to delimit the testicle pairs. For the calculations we used the mean weight of each pair of testicles rather than treating the two in each pair as independent E2F induces p53-independent apoptosis C Holmberg et al reduced testicle size and atrophy of the seminiferous tubules. In line HE3, all ®ve males had this phenotype. Due to the reduced fertility of HE3 females, we could not maintain this line. The loss of female fertility appeared during backcrosses and may have been caused by an eect on ovaries similar to that on testicles. Unfortunately, ovaries were not analysed at this time, since all females were used until old age in attempts to resurrect the line. Previous pHMG-derived transgenes have frequently been expressed in many tissues, but only testis expression is always present (Mehtali et al., 1990) . As general E2F-1 overexpression may be detrimental, it is possible that mice with widespread E2F-1 expression died during embryogenesis. Since testicles are, in a sense, dispensable, we ended up with the two lines expressing the E2F-1 transgene in testicles only.
Line HE5 was more mildly aected, the eects on testicle size were less pronounced. There was a much wider distribution of sizes. However, 36% of the males suered testicular atrophy to a weight never seen in the controls. This number was increased to almost 80% when the DP-1 transgene was also present. The doubletransgenic males had both smaller and histologically more defective testicles than the single-transgenic males. In spite of the variability, which is discussed below, the correlation between transgenic status and testicle sizes is signi®cant (Table 1) .
Histological examination of the testicles and TUNEL assays showed that the reduced size and atrophy were presumably a result of increased apoptosis. Since two independent HMG-E2F-1 lines displayed very similar phenotypes and since the phenotype in the HE5 line could be shown to be potentiated by the presence of either of two independent HMG-DP-1 transgenes, it is unlikely that the phenotypes reported here were spurious eects of the particular transgene integration sites. Rather, testis cells with an E2F-1 concentration above a certain threshold have undergone apoptosis. Since E2F-1 cooperates with DP-1 in DNA-binding, one would predict that this threshold is lower in cells that also overexpress DP-1. Indeed, DP-1 overexpression aggravated the phenotype.
Variegation and penetrance
The moderately E2F-1 expressing line, HE5, has a large variation in testicle sizes. Although the phenotype is clearly related to E2F-1, being aggravated by DP-1 a b c d Figure 9 Atrophy and apoptosis caused by E2F-1 overexpression in a p53 7/7 background. (a and b) show hematoxilin/eosin stained sections of a p53 7/7 testicle with normal morphology and a strongly atrophic HE5 p53 7/7 testicle, respectively. Note that there are remaining normal tubules in (b). TUNEL staining of the p53 7/7 testicle and a moderately atrophic HE5 p53 7/7 testicle in which apoptosis was still detectable are shown in (c and d), respectively. Arrowheads in d point to atrophying tubuli with many TUNEL positive cells. Testicles were taken from 6-week-old animals. Atrophy and apoptosis could also be found in HE5/HD p53 7/7 transgenic testicles (not shown). Initial magni®cations were 1006 production, it is puzzling that the eect strikes so unevenly. The concentrations of E2F-1 transgene mRNA were equal in testicles of dierent sizes according to Northern blots (not shown). Likewise, the concentrations of E2F-1 protein detected by immunological methods in small and normal testicles were indistinguishable. Notably, the total expression in whole testicles was at a very low level, a homeostatic mechanism (Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996) apparently ensuring that large quantities of excess E2F-1 protein do not accumulate. Previous data obtained in tissue culture have suggested that even very low levels of E2F-1 are sucient to induce a phenotype (Helin et al., 1993b; Qin et al., 1994; Lukas et al., 1996) . Whole testicles may therefore not well represent the process going on, since transgenic expression in tissues often occurs in a very heterogenous way among cells of a single type (Dobie et al., 1997) . In our immunohistochemical investigation of apoptosing testicle transgenic E2F production was barely detectable. It was limited to only few cells, however, and the very same cells appeared to be those engaged in apoptosis. Thus, at any one time, few cells may have an excess of E2F protein, an excess that is not very large and that does not contribute signi®cantly to the signal in Western blot of whole testis lysates.
That some mice get more aected than others could have several explanations. First there could be subtle environmental in¯uences on testicle development, second there is a known heterogeneity in the genetic background, and third there is the known phenomenon of variability of expression in connection with variegation. While the ®rst two causes could play a role, we ®nd it striking that the variability occurs in connection with variegation, since some transgenes have shown this type of behavior in an integration-site dependent manner (Bradl et al., 1991; Furth et al., 1994; Robertson et al., 1995; Dobie et al., 1996) .
Variable expression of a transgene has been seen before with the very promoter construct that we used, the HMG promoter (Dobie et al., 1997) . Thus, the simplest interpretation of the variability of testicular atrophy between individuals of our weaker E2F-1 line, HE5, may be that the HMG-E2F-1 transgene has variable and variegated expression at this integration site. In each individual, progenitor cells in the tubuli may thus have a certain likelihood of releasing the transgene from a silenced condition. When this happens in a progenitor cell, its nearest descendants will express the transgene, and the result will be a small group of cells undergoing inappropriate apoptosis, due to excess E2F-1 production. This patchy apoptosis will hit more often in individuals in whom the silencing is less ecient. While apoptosis is the phenomenon we can follow at the cytological level, other eects, like interference with meiosis and dierentiation, may also occur and contribute to the observed phenotype.
p53 not needed for E2F-induced apoptosis in testicles
During the course of our work it was published that overexpression of E2F-1 in mouse megakaryocytes blocks terminal dierentiation and causes hyperproliferation and apoptosis (Guy et al., 1996) . Similarly, ectopic co-expression of dE2F and dDP in the developing eye of Drosophila causes unscheduled progression to S phase and subsequent apoptosis (Asano et al., 1996; Du et al., 1996) . Two recent publications suggest that apoptosis and transactivation are separate functions of E2F-1 (Hsieh et al., 1997; Phillips et al., 1997) , whereas E2F-1 induced S phase progression requires the intact transactivation function (Phillips et al., 1997) . Since the male germ epithelium has a high fraction of proliferating cells, we have been unable to assess whether apoptosis induced by overexpression of E2F-1 or of E2F-1/DP-1 in the testicles of our transgenic mice is preceded by progression into S phase.
The S-phase-promoting and apoptotic functions of E2F-1 have provided a link between the pRB and p53 tumor suppressors. Loss of pRB activity may lead to either apoptosis, if p53 is functional, or proliferation, if p53 is non-functional. The E7 and E6 oncogenes from the human papilloma virus type 16 have been used as transgenes to simulate loss of pRB and loss of p53, respectively. Thus transgenic mice expressing E7, which inactivates pRB, suer cell death, probably by apoptosis, of retinal cells when expressed in retinal photoreceptors. In p53 7/7 mice the same transgene does not cause cell death but rather leads to formation of retinal tumors (Howes et al., 1994) . Similarly, E7 expression interfered with dierentiation and seemed to induce apoptosis in the developing lens. Simultaneous expression of E6 reduced the apoptosis and allowed formation of lens tumors (Pan and Griep, 1994) .
E2F-1 is a prime target of pRB, and E2F-1 overexpression in cell culture has been shown to cause apoptosis in cooperation with p53 (Shan and Lee, 1994; Hiebert et al., 1995; Kowalik et al., 1995; Xu et al., 1995) . Thus, it was highly interesting to investigate if the E2F-1 or E2F-1/DP-1 transgenes would still cause testicular atrophy and apoptosis in a p53 background or would allow excessive growth of the aected cell population. We therefore bred our transgenic mice to a p53 nullizygous background. These mice allowed the remarkable conclusion that all testis phenotypes are unchanged in the p53 7/7 background: Reduced size of testicles and atrophy and apoptosis in the seminiferous tubules were still observed. Concerning oncogenicity, we have no evidence that testicular overexpression of E2F-1 and DP-1 in the absence of p53 should cause hyperplastic growth and/or signi®cantly increase the incidence of testis tumors. The latter ®nding is expected as long as apoptosis is unchanged. Recently E2F-1 has been shown to cause apoptosis in a p53-de®cient cell line (Hsieh et al., 1997; Phillips et al., 1997) in agreement with the in vivo data presented here. Also, the eects of the E7 transgene expressed in the developing lens are not completely annihilated in p53 7/7 mice. Thus, when an E6 transgene was expressed in the E7-expressing and p53
7/7 mice, it reduced the E7-induced apoptosis to a lower level than did p53 7/7 status alone. The E6 protein inactivates the p53 protein but seems to have a further eect on a p53-independent pathway of apoptosis (Pan and Griep, 1995) .
Interestingly, testicular atrophy through unknown mechanisms also occurs in E2F-1 nullizygous mice examined between 9 and 15 months (Yamasaki et al., 1996) , suggesting that E2F-1 is required for homeostasis of testicles in later stages of life. Our data E2F induces p53-independent apoptosis C Holmberg et al indicate that excess E2F-1 causes testicles to undergo atrophic changes early in life, most probably through direct induction of apoptosis. If the eect of the knockout of E2F-1 on testicles is direct, then the concentration of E2F-1 in testicles appears delicately adjusted for proper function. By combining the knockouts of E2F-1 and pRB it should be possible to reveal whether E2F-1 is required for the apoptosis seen in RB nullizygous mice, and whether E2F-1 is required for tumor progression in the absence of pRB. It is possible that apoptosis and proliferation are controlled by distinct members of the E2F family.
Implications for E2F induced apoptosis and tumorigenesis
Further studies in vivo are required to decide whether apoptosis is the general fate of dierent cell types in response to elevated E2F-1/DP-1 concentrations. Possibly, some cell types will undergo p53-dependent apoptosis in response to E2F-1 overexpression, whereas other cell types undergo p53-independent apoptosis. Other tissues yet, may develop hyperplasia or tumors irrespective of p53 status. In agreement with such a model, apoptosis in the central nervous system and in the developing lens of RB nullizygous mouse embryos is dependent on p53, whereas, in the peripheral nervous system, apoptosis also occurs in the absence of p53 (Morgenbesser et al., 1994; Macleod et al., 1996) . Although a few examples have been reported for ampli®cation of the E2F-1 gene in human cell lines (Saito et al., 1995) , no reports have appeared describing overexpression or ampli®cation of E2F-1 in primary tumors. We are currently generating transgenic mice with widespread inducible expression of E2F-1 in order to assess the apoptotic and S-phase-inducing ability of E2F-1 in the presence and absence of p53 in a variety of tissues. In summary, in two mouse lines, E2F-1 transgenes caused atrophy and apoptosis in testicles. Elevated levels of DP-1 augmented the eect. One of these lines was less severely aected due to reduced penetrance in concert with variegation of transgene expression. Remarkably, E2F-1 overexpression in testicles led to apoptosis and atrophy irrespective of the p53 status in the cells.
Materials and methods
Plasmid construction and DNA for microinjection
Plasmid DNA and cloning procedures were standard (Sambrook et al., 1989) . pHMG-E2F-1 was made by inserting a 1350 base pair BamHI cDNA fragment from pCMVE2F-1 (Helin et al., 1992) containing the entire E2F-1 open reading frame into the unique BamHI site of pHMG. pHMG is a vector made for expression in mammalian cells of inserted cDNA sequences (Gautier et al., 1989) , and was a kind gift from Dr Majid Mehtali of Transgene SA, Strassbourg. pHMG-DP-1 was made by inserting a Klenow-®lled 1600 base pair EcoRI fragment of pBSK-DP1 with the entire DP-1 open reading frame (Helin et al., 1993b) into the unique EcoRV site of pHMG. DNA for microinjection was prepared by removal of the pHMG vector backbone with NotI digestion and subsequent gelpuri®cation. The concentration of DNA for injection was adjusted to 2.5 ng/ml in injection buer (0.1 mM EDTA, 10 mM Tris, pH 7.4).
Transgenic mice
Transgenic mice were generated by microinjection into onecell embryos as described (Hogan et al., 1986) . Zygotes for injection were obtained from crosses between C57Bl/ 6xCBA F1 hybrid males and females, purchased from Bommice, Denmark. Successfully injected zygotes were implanted into the infundibula of pseudopregnant NMRI mice.
DNA was extracted with the proteinase K method from tail biopsies and used to determine whether the mice were transgenic. First and second generation transgenic mice were identi®ed by standard Southern blot hybridization using 32 Plabeled probes that were generated with the Random Prime DNA Labeling Kit from Boehringer Mannheim. To screen for HMG-E2F-1 transgenic mice we used the SalI/XhoI fragment of hE2F-1 cDNA (Helin et al., 1992) as template for the random prime; to screen for HMG-DP-1 we used the entire hDP-1 open reading frame present on an EcoRI fragment from pBSK-DP-1. Later generations were screened by PCR, using a three-primer reaction to amplify simultaneously an endogenous HMG-sequence, present in all mice and a fusion-sequence between HMG and either E2F-1 or DP-1, speci®c for the transgenic animals. Sequences for the upstream and downstream HMG-speci®c primers were: 5'-AGTGAGCCCCATGCATGCTAAGTGTTCTTC-3' and 5'-GGTGGGAGGCCACGAAGAGGCC-3', respectively, and downstream primers speci®c for either HMG-DP-1 or HMG-E2F-1 were: 5'-TGCTTCCCGAGCGGGTTGACGGTGG-3' and 5'-GCAGCAGGTCAGGGTCGCAGG-3', respectively. We back-crossed transgenic lines to C57/Bl/6 at least two times before starting to cross-breed HE5 transgenics with HD3 and HD4 transgenics.
p53 knockout mice p53 +/7 mice from an inbred 129 genetic background were generous gifts from Alan R Clarke, Cancer Research Campaign Laboratories, Edinburgh, UK. The mutant p53 gene in these mice carries a deletion from exon 2 to exon 6 made by replacement with a neomycin expression cassette (Clarke et al., 1993) . After one or two back-crosses to C57Bl/6, p53 +/7 mice were crossed with our transgenic mice. We determined p53-status with PCR, using a threeprimer reaction with the ability to generate amplicons speci®c for both wild type and disrupted p53-genes. Primer sequences were: 5'-GTGGTGGTACCTTATGAGCC-3' (located in exon 6), 5'-CAAAGAGCGTTGGGCATGTG-3' (located in intron 7) and 5'-CATCGCCTTCTAT-CGCCTTC-3' (speci®c for the neomycin cassette) as suggested to us by Alan Clarke.
Northern blot hybridization
Total RNA was extracted by the guanidinium thiocyanateacidic phenol-chloroform method essentially as described (Chomczynski and Sacchi, 1987) from tissues that had been ash frozen in liquid nitrogen and pulverized in a precooled mortar. Thirty microgram RNA samples were size-fractionated by standard denaturing agarose gel electrophoresis, blotted and hybridized to probes identical to those described above for Southern blotting.
Western blot analysis
Total protein tissue extracts were made from¯ash frozen tissues. After pulverization, three volumes of swelling buer (20 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM PMSF, 0.5 mM DTT, 25% glycerol) were added on ice and 5 min later NaCl was added to 0.42 M ®nal concentration. Full homogenization was obtained using a Polytron. The lysate was left for 20 min on ice before centrifugation for 30 min at 100 000 g. Supernatants were used for Western blotting and immunoprecipitation. Protein concentration was determined by the Biorad ± Bradford method according to instructions. After SDS-polyacrylamide gel electrophoresis (SDS ± PAGE) of extracts or immunoprecipitates, semi-dry transfer to nitrocellulose membranes was performed as described (Harlow and Lane, 1988) . Membranes were blocked in phosphatebuered saline supplemented with 1% Tween-20 and 5% non-fat dry milk for 1 h before addition of the primary antibody. Monoclonal antibody TFD11 recognizing DP-1 (K Helin, unpublished) was applied as a 1 : 5 dilution of tissue culture supernatant. Rabbit polyclonal anti E2F-1 antibody was applied as 1 : 1500 dilution. After washing, secondary antibodies coupled to horseradish peroxidase (HRP) were allowed to bind. Final visualization was obtained with the ECL reagents according to the manufacturer (Amersham) and ®lm exposure.
E2F-1 immunoprecipitation
E2F-1 was immunoprecipitated from 1 mg of testis extract protein with a combination of two dierent monoclonal antibodies KH20 and KH95 (Helin et al., 1993b) and protein-A Sepharose. Bound immunocomplexes were released in 26SDS loading buer by boiling and the supernatants were used for SDS ± PAGE with subsequent Western blotting as described previously.
Histology
For general views of histological changes, testicles were ®xed in Bouins solution, para®lm-embedded, sectioned, and stained with haematoxilin and eosin. TUNEL assays on testis sections were performed essentially as described (Gavrieli et al., 1992) . Biotinylated dUTP incorporated onto the excess 3'-ends of DNA present in apoptotic cells was detected with the streptavidin/biotin-HRP method (ABComplex from the Duet Kit, DAKO) using 3,3'-diaminobenzidine tetrahydrochloride as chromogenic substrate. TUNEL-stained sections were brie¯y counterstained with haematoxilin and mounted.
Statistics
Means, standard deviations, medians and Mann ± Whitney U-tests were calculated using the StatView 1 Student software (Abacus Concepts).
